RESUMEN
Antioxidants can inhibit atherosclerosis, but it is unclear how inhibition of intimal lipid oxidation relates to atherogenesis. Here we tested the effect of probucol and its metabolite bisphenol on aortic lipid (per)oxidation and atherogenesis in Watanabe heritable hyperlipidemic (WHHL) rabbits. LDL and aortas from rabbits fed probucol contained bisphenol at concentrations comparable to those in bisphenol-treated animals. Bisphenol treatment increased plasma cholesterol slightly, and plasma and aortic alpha-tocopherol more substantially; these parameters were unaffected by probucol. Bisphenol and probucol treatment both enhanced the resistance of circulating LDL to peroxyl radical-induced lipid peroxidation; this was due to bisphenol, not probucol. Only probucol enhanced LDL's resistance to Cu(2+)-induced oxidation. Both bisphenol and probucol treatment strongly inhibited aortic accumulation of hydroperoxides and hydroxides of cholesteryl esters and triglycerides [LO(O)H]. Despite this, however, probucol had a modestly significant effect on the extent of lesion formation; bisphenol had no inhibitory effect. In addition, the extent of atherosclerosis did not correlate with amounts of aortic LO(O)H present, but, as expected, it did correlate with aortic alpha-tocopherol and cholesterol. Together, these results suggest that aortic accumulation of LO(O)H is not required for, nor is alpha-tocopherol depleted during, the initiation and progression of atherogenesis in WHHL rabbits.
Asunto(s)
Aorta/metabolismo , Arteriosclerosis/etiología , Hiperlipidemias/metabolismo , Peroxidación de Lípido , Animales , Hiperlipidemias/complicaciones , Peroxidación de Lípido/efectos de los fármacos , Lípidos/sangre , Lipoproteínas LDL/metabolismo , Masculino , Oxidación-Reducción , Probucol/farmacología , ConejosRESUMEN
Rat liver endothelial cells in primary cultures take up and degrade 125I-labelled human very-low-density lipoproteins (VLDL) in a saturable fashion at physiological triacylglycerol concentrations. The iodinated VLDL are readily taken up by the freshly isolated endothelial cells and degradation products appear in the medium about 30 min after the addition of VLDL to the cultures. Uptake and degradation at 37 degrees C are effectively inhibited by unlabelled human VLDL, low-density lipoproteins (LDL), high-density lipoproteins and lymph chylomicrons, but only modestly by acetylated LDL. Purified apolipoproteins E and C-III:1 also compete with the uptake of iodinated VLDL, but when degradation was studied for longer periods of time, such a competition could not be demonstrated. This may be due to the fact that the added apolipoproteins become associated with the lipoproteins. In binding experiments at 7 degrees C, iodinated apolipoprotein C III:1 bound to the liver endothelial cells in a manner characteristic of receptor binding with a dissociation constant of 0.5 microM. This binding could not only be inhibited by unlabelled apolipoprotein C-III:1 but also by unlabelled apolipoprotein E. The results indicate that rat liver endothelial cells carry receptors for VLDL and that these recognize the apolipoproteins E, C-III and B on the lipoprotein surface. Considering the large endothelial surface and high blood flow through the liver, significant quantities of lipoproteins can be taken up and degraded, thus influencing the levels of circulating lipoproteins in the in vivo situation.
Asunto(s)
Lipoproteínas VLDL/metabolismo , Hígado/metabolismo , Animales , Apolipoproteínas C/metabolismo , Apolipoproteínas E/metabolismo , Transporte Biológico , Células Cultivadas , Quilomicrones/metabolismo , Endotelio/metabolismo , Lipoproteínas HDL/metabolismo , RatasRESUMEN
In an attempt to characterise the apolipoprotein-E-binding proteins of rat liver endothelial cells, we prepared membranes from monolayer cultures of liver endothelial cells as an enriched source of membrane receptors. The membranes could specifically bind iodinated very-low-density lipoproteins (VLDL) and the binding could be inhibited effectively by unlabelled VLDL and high-density lipoproteins, but only moderately by low-density lipoproteins. To identify the binding proteins, we performed immunoprecipitation studies of solubilised iodinated liver endothelial cells and cell membranes, respectively, using purified apolipoprotein E and monospecific polyclonal IgG directed towards this apolipoprotein. The antibodies together with the bound apolipoprotein E and iodinated liver endothelial cell proteins were harvested with staphylococcal protein A-Sepharose. The immunoprecipitates were subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis, and after autoradiography of the dried gel, the Mr of the liver endothelial cell proteins bound to apolipoprotein E could be determined. Two protein bands with molecular masses of 55-60 and 110, and a weak band of 170 kDa could be detected from intact cells. These proteins were specifically precipitated only in the presence of divalent cations, and might represent cell-surface receptors for apolipoprotein-E-containing lipoproteins. Additional bands were seen when cell membranes were used, the most prominent ones having molecular masses of 32 and 35 kDa. These proteins could be of intracellular origin, or they may be degradation products of the other apolipoprotein-E-binding proteins.
Asunto(s)
Apolipoproteínas E/metabolismo , Proteínas Portadoras/metabolismo , Endotelio/metabolismo , Hígado/metabolismo , Citoesqueleto de Actina/metabolismo , Animales , Proteínas Portadoras/aislamiento & purificación , Membrana Celular/metabolismo , Endotelio/citología , Hígado/citología , Masculino , Proteínas de la Membrana/aislamiento & purificación , Proteínas de la Membrana/metabolismo , Peso Molecular , Pruebas de Precipitina , Ratas , Ratas EndogámicasRESUMEN
The effect of felodipine on lipoprotein metabolism ex vivo and in vivo was investigated. In the ex vivo studies mice were given felodipine (40-125 mumol/kg body weight) or vehicle for one week. Peritoneal macrophages from these animals and controls were isolated and used in binding and degradation studies with human iodinated acetylated LDL (Ac-LDL). Macrophages from felodipine-treated mice showed a significant decrease of binding and degradation of Ac-LDL compared to macrophages from control animals (P < 0.05). The in vivo studies were performed in rats pretreated with felodipine or vehicle. To determine the distribution and plasma turnover of LDL and Ac-LDL, 125I-tyramine cellobiose labelled LDL or Ac-LDL were given i.v. No differences in the removal rate of Ac-LDL or LDL were observed between felodipine-treated or untreated rats. However, an increased uptake of Ac-LDL could be seen in the liver of the felodipine-treated rats. This increased uptake could be ascribed to the parenchymal cells because no differences in uptake could be seen in the liver endothelial cells. However, a significant decreased uptake was seen in the Kupffer cells and in the spleen, a macrophage-rich organ, of the felodipine-treated rats. The present study suggests a possible mechanism behind the antiatherogenic effects of calcium antagonists, a decreased uptake of atherogenic modified lipoproteins by peripheral macrophages and an increased uptake by the liver.
Asunto(s)
Felodipino/farmacología , Lipoproteínas LDL/metabolismo , Macrófagos/metabolismo , Acetilación , Animales , Células Cultivadas , Humanos , Riñón/citología , Riñón/metabolismo , Hígado/citología , Hígado/metabolismo , Pulmón/citología , Pulmón/metabolismo , Masculino , Ratones , Cavidad Peritoneal/citología , Ratas , Ratas Sprague-Dawley , Bazo/citología , Bazo/metabolismoRESUMEN
Even when administered at a comparatively low level, dietary cholesterol produces significant changes in the properties of plasma lipoproteins in rats, particularly the d less than or equal to 1.006 g/ml fraction (VLDL). The occurrence of these changes is promoted by dietary casein. To test the hypothesis that these dietary-induced perturbations might include properties influencing lipoprotein-cell interactions of relevance to atherogenesis, cultured mouse peritoneal macrophages were incubated with VLDL isolated from male rats fed on diets containing either 0, 0.25 or 0.5% cholesterol with casein or soybean protein, respectively, as the sole source of protein. No increase in cholesteryl ester content, and a comparatively small rise in triglyceride content, was observed in macrophages incubated with VLDL from rats fed on cholesterol-free diets. In contrast, a significant and apparently saturable cellular accumulation of cholesteryl esters as well as triglycerides was produced by VLDL from cholesterol-fed rats. The curves showing cellular lipid accumulation versus VLDL-protein (or VLDL-cholesterol) content in the cell medium indicated different cellular affinity for VLDL from casein-fed rats in comparison with VLDL from soybean protein-fed rats. The apoprotein composition of VLDL differed between groups of rats fed on different types of dietary protein with higher proportions of apo C's in the casein-fed rats. In addition, cholesterol feeding resulted in increased proportions of apo A-I and apo A-IV in the plasma VLDL fraction.
Asunto(s)
Caseínas/administración & dosificación , Ésteres del Colesterol/metabolismo , Colesterol en la Dieta/farmacología , Lipoproteínas VLDL/fisiología , Macrófagos/efectos de los fármacos , Proteínas de Vegetales Comestibles/administración & dosificación , Triglicéridos/metabolismo , Animales , Apoproteínas/análisis , Células Cultivadas , Colesterol/análisis , Hiperlipidemias/sangre , Lipoproteínas VLDL/análisis , Macrófagos/metabolismo , Masculino , Ratones , Peritoneo/citología , Ratas , Ratas Endogámicas , Proteínas de SojaRESUMEN
The purpose of the present study was to characterize possible effects of dietary-induced plasma lipid elevations on the development of arterial lesions in spontaneously hypertensive rats (SHR) and to reveal any influence of treatment with metoprolol on these parameters. Metoprolol treatment caused an 8% decrease in heart rate and a 13% decrease in blood pressure and led to a rise in plasma triglycerides, 24%, 17% and 34% after 1, 3 and 6 months of metoprolol treatment, respectively. However, no effect on plasma triglycerides was observed after 9 months of metoprolol treatment while a reduced cholesterolemic response was observed. Intimal proliferations containing accumulations of lipids were observed in small intramural branches of coronary arteries (greater than 100 microns) in 11 of 31 control rats fed the atherogenic diet for 9 months. In contrast, similar changes were observed in only 1 of 34 metoprolol-treated rats fed an otherwise identical diet. The corresponding figures for the frequency of lipid containing intimal plaques in aorta were 6/19 in controls and 2/24 in the metoprolol-treated group.
Asunto(s)
Arteriosclerosis/prevención & control , Hipertensión/tratamiento farmacológico , Lípidos/sangre , Metoprolol/uso terapéutico , Animales , Aorta/patología , Vasos Coronarios/patología , Dieta Aterogénica , Hipertensión/metabolismo , Masculino , Ratas , Ratas Endogámicas SHR , Factores de TiempoRESUMEN
The saturable uptake and degradation of 125I-labelled human very low density lipoproteins in cultured rat liver endothelial cells could be effectively inhibited by high density lipoproteins (HDL) from normal subjects. Up to eight times more HDL (in relation to cholesterol content) was needed from patients with hyperlipoproteinaemia (HLP) type III to give the same inhibition. The HDL apolipoprotein (apo) E concentrations that were needed to give the same inhibition as normal HDL apo E were between 3 and 50 times higher in HLP type III. Our results suggest that the lipoprotein abnormality in HLP type III not only affects chylomicron remnant metabolism but also the composition and function of HDL.
Asunto(s)
Hiperlipoproteinemia Tipo III/sangre , Lipoproteínas HDL/fisiología , Lipoproteínas VLDL/metabolismo , Hígado/metabolismo , Adulto , Animales , Apolipoproteínas E/fisiología , Grasas de la Dieta/administración & dosificación , Endotelio/citología , Endotelio/enzimología , Endotelio/metabolismo , Humanos , Hiperlipoproteinemia Tipo III/etiología , Radioisótopos de Yodo , Lipasa/fisiología , Lipoproteínas HDL/metabolismo , Lipoproteínas VLDL/antagonistas & inhibidores , Hígado/citología , Persona de Mediana Edad , RatasRESUMEN
In order to investigate whether initial plasma lipid concentrations could be used to distinguish between high and low responders to an atherogenic diet, rabbits were divided into 3 groups according to their plasma concentrations of cholesterol and phospholipids after 4 weeks on a standard rabbit diet. Plasma cholesterol and phospholipid levels were less than 0.5 mM, less than 1.1 mM, respectively, in group 1 (n = 17), greater than 0.5 mM, less than 1.1 mM, in group 2 (n = 13), and greater than 0.5 mM, greater than or equal to 1.1 mM, in group 3 (n = 14). After 7 weeks on a diet containing 0.25% cholesterol and 3% coconut oil, animals in groups 1 and 2 had a lower increase in their plasma lipid levels compared with group 3. Half of each group was then treated with the beta 1-adrenoceptor antagonist metoprolol during the next 14 weeks on the atherogenic diet. At the end of the study, the extent of atherosclerosis both in the aortas and in the coronary arteries of the control animals showed a positive correlation to plasma cholesterol and to plasma phospholipid concentrations integrated over time. The metoprolol-treated animals in groups 1 and 2 had a reduction of atherosclerosis compared with their respective controls. We conclude that subpopulations of rabbits that react differently on an atherogenic diet can be identified by their initial plasma lipid levels, and that metoprolol treatment of low responders to an atherogenic diet significantly reduces atherosclerotic lesions of the aorta.
Asunto(s)
Arteriosclerosis/tratamiento farmacológico , Dieta Aterogénica , Metoprolol/uso terapéutico , Animales , Aorta/patología , Apolipoproteínas/sangre , Arteriosclerosis/etiología , Arteriosclerosis/patología , Colesterol/sangre , Vasos Coronarios/patología , Modelos Animales de Enfermedad , Ácidos Grasos no Esterificados/sangre , Fosfolípidos/sangre , Conejos , Valores de Referencia , Especificidad de la Especie , Factores de Tiempo , Triglicéridos/sangreRESUMEN
Structure-activity relationships are presented for some representative compounds from a novel series of potent inhibitors of lipid peroxidation. The compounds are indenoindole derivatives with oxidation potentials in organic solvents of between 0.2 and 1.5 V. Two of these compounds, cis-5,5a,6,10b-tetrahydro-9-methoxy-7-methylindeno[2,1-b]indole (H 290/51) with an oxidation potential of 0.32 V and cis-4b,5,9b,10- tetrahydro-8-methoxy-6-methylindeno[1,2-b]indole (H 290/30) with an oxidation potential of 0.30 V, have been tested more extensively and compared with reference compounds in several pharmacological models of lipid peroxidation. The inhibitory potencies (pIC50) of the compounds in respect to Fe/Ascorbate-induced production of thiobarbituric acid-reactive substances (TBARS) in a suspension of purified soybean lecithin were calculated. These data are 8.2 for H 290/51; 8.0 for H 290/30; 5.6 for vitamin E; and 6.6 for butylated hydroxytoluene (BHT). In isolated rat renal tissue subjected to hypoxia and reoxygenation, the potency for inhibition of TBARS formation is 6.9 for H 290/51, 6.9 for H 290/30, and <5 for vitamin E. In oxidative modification of low-density lipoproteins (LDL) induced by mouse peritoneal macrophages, the corresponding pIC50 values for TBARS inhibition for each compound are: 8.7, 8.3, <5, and 6.9, respectively. It is concluded that the synthetic indenoindoles are potent antioxidants. The results suggest that indenoindoles such as H 290/51 and H 290/30 could be useful as therapeutic agents in pathophysiological situations where lipid peroxidation plays an important role.
Asunto(s)
Antioxidantes/química , Indoles/química , Peroxidación de Lípido , Animales , Relación Dosis-Respuesta a Droga , Ratas , Ratas Sprague-Dawley , Relación Estructura-ActividadRESUMEN
In the accompanying paper it was shown that the new antioxidant, H 290/51 (cis-5,5a,6,10b-tetrahydro-9-methoxy-7-methylindenol[2,1-b]indole) , is a powerful antioxidant in several pharmacological models of lipid peroxidation and could be useful as a therapeutic agent in pathophysiological situations where lipid peroxidation plays an important role. In the present study, we characterised H 290/51 as an inhibitor of peroxidation of pure methyl linoleate. H 290/51 almost completely inhibited peroxidation induced by a lipid-soluble initiator at 37 degrees C during the induction period, both in an aqueous solution of micelles in the presence of detergents and in a homogeneous ethanol solution. In both systems, the time of the induction period was linearly related to the concentration of H 290/51. In the ethanol solution, ascorbic acid had a sparing effect on H 290/51, indicating effective interference with radical chain propagation. In aqueous solution with micelles of methyl linoleate made with the nonionic detergents Triton X-100 or Lubrol PX, ascorbic acid did not inhibit peroxidation. However, in these micelles, H 290/51 showed a concentration-dependent extension of the induction period by ascorbic acid, suggesting recycling. In the presence of the zwitterionic detergent CHAPS, although a clear induction period is seen with H 290/51, no recycling by ascorbic acid was found. The ability of H 290/51 to recycle in aqueous solutions, thus depends on the micellar composition.
Asunto(s)
Antioxidantes/química , Ácido Ascórbico/química , Indoles/química , Oxidación-Reducción/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Cinética , Consumo de OxígenoRESUMEN
In order to study the relationships between serum lipoprotein lipid concentrations and the concentrations of apo E in serum and interstitial fluid, we have developed a specific, sensitive and rapid radioimmunoassay for this apolipoprotein. Studies of the interstitial fluid lipoproteins and of the gradient between the lipoprotein concentrations in interstitial fluid and serum may add to our understanding of the development of atherosclerosis and xanthomatosis. Serum, interstitial fluid, lipoproteins or standards were incubated with 125I-labelled apo E and rabbit antiserum against apo E for 90-120 min at room temperature. The immune complexes were harvested with the use of formalin-treated staphylococci. The displacement curves produced by standard and samples of serum, interstitial fluid and isolated lipoproteins were linear in logit-log plots and had identical slopes. Delipidation did not change the results and the recovery of added apo E to a serum sample was 96 +/- 5% (n = 5). Apo E was found in all major lipoprotein classes and the concentrations of apo E in serum and in interstitial fluid were 36 +/- 19 mg/l and 8 +/- 4 mg/l, respectively, in normals (n = 21) and 305 +/- 125 mg/ml and 20 +/- 9 mg/l, respectively, in patients with HLP type III (n = 11). Highly significant positive correlations were found in HLP type III between the interstitial fluid level of apo E and the corresponding concentrations of cholesterol and triglyceride. Interstitial fluid apo E concentrations were significantly correlated to apo E but not to the lipid levels in serum, indicating that only some subclasses of the serum lipoproteins are transported to the interstitial compartment.
Asunto(s)
Apolipoproteínas E/metabolismo , Espacio Extracelular/metabolismo , Hiperlipoproteinemia Tipo III/metabolismo , Apolipoproteínas E/sangre , Colesterol/sangre , Femenino , Humanos , Lipoproteínas/sangre , Lipoproteínas/metabolismo , Masculino , Microquímica , Persona de Mediana Edad , Radioinmunoensayo , Triglicéridos/sangreRESUMEN
Three groups of rats were maintained on diets containing different proportions of trans fatty acids (0, 18.3 or 36.6% of the total fatty acids) for eight weeks. No differences in body weight were observed among the three groups, but the fat cell size, determined in epididymal fat, differed significantly between the controls and the rats fed diets containing trans fatty acids. The supernatant obtained by centrifuging homogenates of liver from the rats at 9000 X g (S-9 fraction) was used as an activator in a bacterial test for mutagenicity of 2-aminofluorene and aflatoxin B1 using Salmonella typhimurium strains TA 98 and TA 100, respectively. The mutagenicities of 2-aminofluorene in strain TA 98 and of aflatoxin B1 in strain TA 100 were significantly lower with the liver S-9 fraction from rats fed a diet containing 36.6% trans fatty acids than with the liver S-9 fraction from rats fed a control diet with no trans fatty acids.
Asunto(s)
Aflatoxinas/metabolismo , Grasas de la Dieta/farmacología , Ácidos Grasos/farmacología , Fluorenos/metabolismo , Microsomas Hepáticos/efectos de los fármacos , Tejido Adiposo/citología , Tejido Adiposo/efectos de los fármacos , Aflatoxina B1 , Animales , Peso Corporal , Masculino , Membranas/enzimología , Microsomas Hepáticos/enzimología , Pruebas de Mutagenicidad , Ratas , Ratas EndogámicasAsunto(s)
Apolipoproteínas/sangre , Clofibrato/análogos & derivados , Ácido Clofíbrico/análogos & derivados , Lípidos/sangre , Lipoproteínas/farmacología , Adulto , Bezafibrato , Glucemia , Peso Corporal , Colesterol/sangre , Ácido Clofíbrico/efectos adversos , Ácido Clofíbrico/farmacología , Ésteres , Ácidos Grasos/sangre , Femenino , Humanos , Insulina/sangre , Lipoproteínas LDL/sangre , Lipoproteínas VLDL/sangre , Masculino , Persona de Mediana Edad , Triglicéridos/sangreAsunto(s)
Lipoproteína Lipasa/metabolismo , Tejido Adiposo/enzimología , Animales , Radioisótopos de Carbono , Bovinos , Células Cultivadas , Femenino , Heparina , Humanos , Indicadores y Reactivos , Cinética , Lipoproteína Lipasa/sangre , Lipoproteína Lipasa/aislamiento & purificación , Leche/enzimología , Técnica de Dilución de RadioisótoposAsunto(s)
Antioxidantes/farmacología , Arteriosclerosis/prevención & control , Angioplastia Coronaria con Balón/efectos adversos , Animales , Anticolesterolemiantes/farmacología , Arterias/efectos de los fármacos , Arterias/fisiología , Arteriosclerosis/fisiopatología , Arteriosclerosis/terapia , Femenino , Humanos , Lipoproteínas LDL/sangre , Lipoproteínas LDL/química , Masculino , Oxidación-Reducción , Probucol/farmacología , Vasodilatación/efectos de los fármacos , Vasodilatación/fisiología , Vitamina E/farmacologíaRESUMEN
Lipoprotein lipase and salt-resistant lipase were isolated from human post-heparin plasma. The proteins of human post-plasma lipoprotein lipase and salt-resistant lipase were identified and demonstrated to be immunologically different. Significant differences between the two enzymes in their relative amino acid composition were demonstrated, which indicates that the two enzymes are different proteins. When analysed by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, the enzymes seemed to have monomer molecular weights similar to that of lipoprotein lipase purified from bovine milk.
Asunto(s)
Lipasa/sangre , Lipoproteína Lipasa/sangre , Aminoácidos/análisis , Animales , Bovinos , Electroforesis en Gel de Poliacrilamida , Heparina , Humanos , Inmunodifusión , Inmunoglobulina G , Lipasa/inmunología , Lipasa/aislamiento & purificación , Lipoproteína Lipasa/inmunología , Lipoproteína Lipasa/aislamiento & purificación , Leche/enzimología , Cloruro de SodioRESUMEN
1. Commercially available bovine serum albumin as Cohn fraction V was demonstrated to contain small amounts of apolipoprotein-CII. 2. This apolipoprotein activated lipoprotein lipase in the same way as apolipoprotein-CII purified from human very-low-density lipoproteins.
Asunto(s)
Apolipoproteínas/análisis , Albúmina Sérica/análisis , Animales , Bovinos , Femenino , Humanos , Cinética , Lipoproteína Lipasa/metabolismo , Leche/enzimologíaRESUMEN
Apolipoprotein (apo) C-II is an activator of lipoprotein lipase, while apo C-III has the ability to inhibit apo C-II activated lipolysis. In order to study further the relationship between lipoprotein lipase mediated hydrolysis and the serum concentrations of apo C-II and apo C-III we have developed radioimmunoassays for these apolipoproteins. Apo C-II and apo C-III were isolated from very low density lipoproteins (VLDL) by ion exchange chromatography. Apo C-II was further purified by affinity-chromatography. The purity of the two proteins was determined to be greater than 98% by polyacrylamide gel electrophoresis and immunodiffusion. The purified apolipoproteins were used as antigens, assay standards and labels. Formalin-treated Staphylococcus aureus Cowan I was used for immunoprecipitation and were shown to give rapid uptake of immune complexes that could easily be harvested by centrifugation. The assays were shown to be sensitive (10 micrograms/l), specific, precise (inter- and intra-assay coefficients of variation below 10%), rapid (completed in less than 6 h) and simple to perform. Delipidation of serum and lipoproteins had no effect on the results, indicating that the immunologically active sites of apo C-II and apo C-III are exposed to the aqueous environment under assay conditions. Serum apo C-II and apo C-III levels of normolipidaemic subjects were approximately 25 mg/l and 110 mg/l, respectively. Highly significant positive correlations were found between VLDL apo C-II and VLDL apo C-III, respectively, and VLDL triglycerides, VLDL cholesterol and total serum TG. There was also a highly significant correlation between the HDL cholesterol concentration and the HDL apo C-III concentration.
Asunto(s)
Apolipoproteínas C , Apolipoproteínas/sangre , Radioinmunoensayo/métodos , Apolipoproteína C-II , Apolipoproteína C-III , Humanos , Hiperlipoproteinemias/sangre , Triglicéridos/sangreRESUMEN
Lipoprotein lipase of high purity has been isolated from bovine milk by affinity chromatography on heparin-Sepharose, adsorption to Cgamma-aluminum hydroxide gel, and intervent dilution chromatography on heparin-Sepharose. Chemical analysis shows that the enzyme is a glycoprotein containing 8.3% carbohydrate. The monomer molecular weight, determined under reducing conditions in 6.6 M guanidine HCl by sedimentation equilibrium ultracentrifugation and analytical gel chromatrgraphy, is 48,300 and 50,800, respectively. Analyses of the sedimentation coefficient (SO20,w=5.40 S) and the diffusion coefficient (DO20,w=48.8 mum2/s) in a buffer of physiological pH and ionic strength yield a molecular weight of 96,900. In solution, the native enzyme thus appears to be a dimer of presumably identical subunits.
Asunto(s)
Lipoproteína Lipasa , Leche/enzimología , Aminoácidos/análisis , Animales , Carbohidratos/análisis , Bovinos , Cromatografía de Afinidad , Estabilidad de Medicamentos , Femenino , Glicerol/farmacología , Glicina/farmacología , Inmunodifusión , Lipoproteína Lipasa/aislamiento & purificación , Lipoproteína Lipasa/metabolismo , Peso MolecularRESUMEN
Semipurified diets containing 0.5% cholesterol were used in a 9-month study with spontaneously hypertensive male rats to characterize the effects of the protein source (casein vs. soybean protein), and the selective beta 1-adrenoceptor antagonist metoprolol on both lipid levels in blood plasma and the aorta, and on the morphology of intramural branches of coronary arteries. Raised blood lipid levels were observed in these rats. A significant decline in HDL2 cholesterol took place, while plasma cholesterol belonging to lipoprotein fractions of lower density increased. Metoprolol treatment led to a substantial elevation of the plasma triacylglycerol level and, with time, a reduced cholesterolemic response. The use of soybean protein instead of casein had a persistent plasma lipid-lowering effect. Arteriosclerotic changes in the form of musculo-elastic thickenings, intimal cushions and homogeneous hyalin deposits appeared in the intramural coronary arteries of rats in all groups after 9 months on the diet. However, intimal deposition of lipid was only present in rats belonging to the casein group not treated with metoprolol. Rats of this group also showed more severe myocardial lesions in the form of scar tissue with or without inflammatory cell reaction.